Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Current Assets (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Current Assets for 15 consecutive years, with $264.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 41.47% to $264.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $264.1 million, a 41.47% decrease, with the full-year FY2024 number at $279.2 million, down 33.17% from a year prior.
  • Current Assets was $264.1 million for Q3 2025 at Usana Health Sciences, up from $261.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $451.2 million in Q3 2024 to a low of $261.9 million in Q2 2025.
  • A 5-year average of $365.7 million and a median of $377.3 million in 2021 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: surged 30.14% in 2021, then plummeted 41.47% in 2025.
  • Usana Health Sciences' Current Assets stood at $368.4 million in 2021, then grew by 4.33% to $384.4 million in 2022, then increased by 8.68% to $417.7 million in 2023, then crashed by 33.17% to $279.2 million in 2024, then dropped by 5.42% to $264.1 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Current Assets are $264.1 million (Q3 2025), $261.9 million (Q2 2025), and $281.4 million (Q1 2025).